IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,194,581 | +126.7% | 116,300 | -46.0% | 0.01% | -74.1% |
| Q2 2022 | $968,000 | +259.9% | 215,198 | +280.8% | 0.03% | +285.7% |
| Q1 2022 | $269,000 | +30.0% | 56,516 | +102.9% | 0.01% | +16.7% |
| Q4 2021 | $207,000 | +168.8% | 27,860 | +133.1% | 0.01% | +20.0% |
| Q4 2020 | $77,000 | -76.9% | 11,954 | -81.7% | 0.01% | -77.3% |
| Q4 2019 | $333,000 | +42.3% | 65,262 | -32.5% | 0.02% | +57.1% |
| Q3 2019 | $234,000 | +169.0% | 96,640 | +141.6% | 0.01% | +40.0% |
| Q2 2019 | $87,000 | – | 40,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |